ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Prostate Cancer trials near Seattle, WA, USA:

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

Seattle, Washington, United States and 92 other locations

This is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate...

Active, not recruiting
Metastatic Prostate Cancer
Drug: Apalutamide
Drug: Abiraterone acetate

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Seattle, Washington, United States and 11 other locations

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Seattle, Washington, United States and 7 other locations

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Tacoma, Washington, United States and 24 other locations

is a multi-center, open-label Phase 1/2 trial evaluating the safety and efficacy of AB-3028 in subjects with metastatic castration resistant prostate...

Enrolling
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Biological: AB-3028

Phase 1, Phase 2

ArsenalBio

Seattle, Washington, United States and 8 other locations

The study will be conducted in 4 parts and will commence with dose escalation of VIR-5500 as a monotherapy (Part 1), followed by combination escalati...

Enrolling
Hormone-refractory Prostate Cancer
Combination Product: ARSI
Drug: VIR-5500

Phase 1

Vir Biotechnology

Seattle, Washington, United States and 11 other locations

The primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an...

Enrolling
Prostate Cancer
Drug: GnRH Antagonist
Drug: Xaluritamig

Phase 1

Amgen
Amgen

Seattle, Washington, United States and 8 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Seatle, Washington, United States and 43 other locations

This is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate...

Enrolling
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer (Adenocarcinoma)
Drug: ACE-232 tablets

Phase 1

Acerand Therapeutics (Hong Kong) Limited

Seattle, Washington, United States of America and 7 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Seattle, Washington, United States and 12 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems